Benzinga's Top #PreMarket Losers

Loading...
Loading...
Esperion Therapeutics IncESPR
shares dropped 11.32 percent to $89.15 in pre-market after falling 0.24 percent on Tuesday.
Francesca's Holdings Corp FRAN
shares fell 5.16 percent to $15.25 in pre-market trading. Francesca's reported Q4 earnings of $0.17 per share on revenue of $95 million. The company expected Q2 earnings of $0.81 to $0.90 per share, on revenue of $104 million to $107 million.
Regeneron Pharmaceuticals Inc REGN
shares declined 3.34 percent to $508.50 in pre-market trading. The FDA Panel has recommended the approval of Sanofi and Regeneron's Praluent.
Gulfport Energy Corporation GPOR
shares tumbled 2.82 percent to $44.09 in pre-market trading. Gulfport Energy announced an offering of 10 million common shares.
bluebird bio Inc BLUE
fell 2.63 percent to $181.73 in pre-market trading after dropping 1.05 percent on Tuesday.
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...